[1] 屈斌,张倩,高弼虎,维持性血液透析患者不同血管通路类型的临床特征及全因死亡差异比较[J].中国血液净化,2021 20(6):367-72.
[2] Thurlow JS, Joshi M, Yan G, et al. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy[J].Am J Nephrol,2021,52(2):98-107.
[3] Shoji T, Abe T, Matsuo H, et al. Chronic kidney disease, dyslipidemia, and atherosclerosis[J].J Atheroscler Thromb,2012,19(4):299-315.
[4] Iseki K, Fukiyama K: Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis[J]. Am J Kidney Dis,2000,36(4):820-825.
[5] Horita Y, Namura M, Ikeda M, et al. Serial cardiac influence of volume overload induced by interventional therapy for central venous stenosis or occlusion in chronic hemodialysis patients[J].J Cardiol,2011,57(3):316-324.
[6] 周婷,张爱华.维持性血液透析患者的血压管理[J].中国血液净化,2021,20(5):294-296.
[7] 汪倩,朱诗瑶,陆笛,等.动脉粥样硬化性心血管疾病风险标志物研究进展[J].检验医学,2021,36(4):447-452.
[8] Morena M, Gausson V, Mothu N, et al. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile[J].Blood Purif,2008,26(3):300-310.
[9] Mizuiri S, Nishizawa Y, Doi T, et al. Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis[J].Ren Fail,2021,43(1):371-380.
[10] 谢院生. 慢性肾脏病的诊断与管理[A].中华国医肾病专科经方大师研修班暨全国中医药配合透析干预肾衰竭综合征科研协作专题论坛论文选集[C]. 2017:20.
[11] Burlacu A, Genovesi S, Basile C, et al. Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies[J].J Nephrol,2021,34(1):39-51.
[12] 吴杰,闭雄杰,廖婷婷.血液透析患者颈动脉内中膜厚度与血清学标志物及心血管疾病的相关性研究[J].当代医学,2021,27(10):166-168
[13] Ohtake T, Ishioka K, Honda K, et al. Impact of coronary artery calcification in hemodialysis patients: Risk factors and associations with prognosis[J].Hemodial Int,2010,14(2):218-225. |
